Back
Standard BioTools Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
24
LAB
Standard BioTools
Last Price:
$1.08
Seasonality Move:
-1.36%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and LAB is experiencing slight buying pressure.
Standard BioTools Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.09 | Sell |
20-day SMA: | 1.14 | Sell |
50-day SMA: | 1.14 | Sell |
200-day SMA: | 1.61 | Sell |
8-day EMA: | 1.09 | Sell |
20-day EMA: | 1.12 | Sell |
50-day EMA: | 1.18 | Sell |
200-day EMA: | 1.56 | Sell |
Standard BioTools Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 46.22 | Sell |
Chaikin Money Flow: | 108548 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.08 - 1.2) | Sell |
Bollinger Bands (100): | (1.05 - 1.63) | Sell |
Standard BioTools Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Standard BioTools Stock
Is Standard BioTools Stock a Buy?
-
Standard BioTools share price is 1.08 while LAB 8-day simple moving average is 1.09, which is a Sell signal.
-
The stock price of LAB is 1.08 while Standard BioTools 20-day SMA is 1.14, which makes it a Sell.
-
Standard BioTools 50-day simple moving average is 1.14 while LAB share price is 1.08, making it a Sell technically.
-
LAB stock price is 1.08 and Standard BioTools 200-day simple moving average is 1.61, creating a Sell signal.
LAB Technical Analysis vs Fundamental Analysis
Sell
24
Standard BioTools (LAB)
is a Sell
Is Standard BioTools a Buy or a Sell?
-
Standard BioTools stock is rated a SellThe current Standard BioTools [LAB] share price is $1.08. The Score for LAB is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Standard BioTools Stock Info
Market Cap:
390.1M
Price in USD:
1.08
Share Volume:
1.6M
Standard BioTools 52-Week Range
52-Week High:
2.74
52-Week Low:
0.95
Sell
24
Standard BioTools (LAB)
is a Sell
Standard BioTools Share Price Forecast
-
What is the Standard BioTools stock price today?The Standard BioTools stock price is 1.08 USD today.
-
Will LAB stock go up or go down?Standard BioTools> share price is forecast to RISE/FALL based on technical indicators
-
Is Standard BioTools overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Standard BioTools is overvalued.
Is Standard BioTools Stock a Buy?
-
Standard BioTools share price is 1.08 while LAB 8-day exponential moving average is 1.09, which is a Sell signal.
-
The stock price of LAB is 1.08 while Standard BioTools 20-day EMA is 1.12, which makes it a Sell.
-
Standard BioTools 50-day exponential moving average is 1.18 while LAB share price is 1.08, making it a Sell technically.
-
LAB stock price is 1.08 and Standard BioTools 200-day simple moving average is 1.56, creating a Sell signal.
Fundamental Analysis of Standard BioTools
Is Standard BioTools a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.08 per share, and an increase next year of $0.05 per share.
Technical Analysis of Standard BioTools
Should I short Standard BioTools stock?
-
LAB Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Standard BioTools is a Sell
-
Standard BioTools Relative Strength Index (RSI) is 46.22, which suggest Standard BioTools is oversold
-
The Bollinger Bands (25) for Standard BioTools is (1.08 - 1.2), which suggest Standard BioTools is a Sell
-
The Bollinger Bands (100) for Standard BioTools is (1.05 - 1.63), which suggest Standard BioTools is a Sell
* Standard BioTools stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.